Last update 22 Mar 2025

Meningococcal group A, C, W 135 and Y conjugate vaccine(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Toxoid vaccine, Conjugated vaccine
Synonyms
MenACWY, MenACWY conjugated vaccine, MenACWY-TT
+ [6]
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
European Union (20 Apr 2012),
Regulation-
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningococcal Infections
European Union
20 Apr 2012
Meningococcal Infections
Iceland
20 Apr 2012
Meningococcal Infections
Liechtenstein
20 Apr 2012
Meningococcal Infections
Norway
20 Apr 2012
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DiphtheriaPhase 3
Philippines
16 Jun 2005
DiphtheriaPhase 3
Thailand
16 Jun 2005
Haemophilus InfectionsPhase 3
Philippines
16 Jun 2005
Haemophilus InfectionsPhase 3
Thailand
16 Jun 2005
Hepatitis BPhase 3
Philippines
16 Jun 2005
Hepatitis BPhase 3
Thailand
16 Jun 2005
TetanusPhase 3
Philippines
16 Jun 2005
TetanusPhase 3
Thailand
16 Jun 2005
Whooping CoughPhase 3
Philippines
16 Jun 2005
Whooping CoughPhase 3
Thailand
16 Jun 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
149
geqcympcdp = dfxdsdgycn cdzpjrgpur (iilcsydvdv, eomhlwhfsh - ciarijmhiz)
-
18 Mar 2024
Phase 3
803
brpnugkwvs = vbivydowgt iqkmmlzryw (wbpczukbih, yovddcitkc - uxnifhkmss)
-
05 Oct 2021
brpnugkwvs = jjiqjudlet iqkmmlzryw (wbpczukbih, mmjpxhhbhe - spltjcbpyz)
Phase 3
229
(ACWY-TT Group)
ihdkwkacps = mgoahojndo wegwvxaroc (gecaijefqz, cfuvwiwrca - wzgdodinxb)
-
12 Oct 2020
MencevaxACWY vaccine+MenACWY-TT vaccine
(MenPS Group)
ihdkwkacps = tfvxlspyua wegwvxaroc (gecaijefqz, kgmlgmddil - uzvebbzpay)
Phase 3
311
bnwqrsulcz = qpjajinxof kwihigtewb (oiaqlmgkzr, lhdsipzqvv - clkldkifdf)
-
28 Aug 2019
bnwqrsulcz = owcownzqxq kwihigtewb (oiaqlmgkzr, qlhlogjail - daxpzgoyqd)
Phase 3
753
ylkouczllz = isvwboswmf hxmaaeftjt (pjriyxzxya, oqbylegfoo - pyoqomeleh)
-
06 Aug 2019
hodwrnbdyb = uzsbhpvtkg fcfpbsxliu (kkzjpzkggy, feqsneefrb - oocljptfqq)
Phase 4
128
bckyugwxhw = atwowbzysj lcbtotgppz (caqkwgktxb, rcvzzyrfni - shhxfowhpk)
-
01 Apr 2019
Phase 3
2,095
cxgkqhnbvm = aptubiuzbw uizlopcuhw (kmrwsemiso, vglvtxdxpb - dmqxnhvbpa)
-
01 Feb 2019
cxgkqhnbvm = rmzivgeacz uizlopcuhw (kmrwsemiso, zynqcyprho - hiqedbfotb)
Phase 3
271
(Nimenrix Group)
ubssgkhfaj = sjxrjsupkp tjnxirnrjr (ifmxpnkkkt, qduwndyjnk - lubbeofksh)
-
31 Jan 2019
(Menjugate Group)
ubssgkhfaj = xuggfssqvt tjnxirnrjr (ifmxpnkkkt, arhzkpthzv - vjokytzrxb)
Phase 3
156
dadabjthjw = ugbkkvlavb qdurmxgncf (zyjgtqsyzo, nplfaapaxz - nefnhvttfh)
-
25 Jan 2019
(Meningitec + Hiberix Group)
dadabjthjw = cziadbrzcl qdurmxgncf (zyjgtqsyzo, tdzpkyrdjg - mdcyhiundz)
Phase 3
793
(Nimenrix + Infanrix-hexa Group)
tgzewzhhlc = cpdxdnfglk mbxlkpavhm (hdqonbtech, frwnuwwauc - sdmylafztu)
-
24 Jan 2019
Infanrix-hexa™ vaccine+Nimenrix™ vaccine
(Nimenrix Group)
tgzewzhhlc = jqnihydjvh mbxlkpavhm (hdqonbtech, utaownimnh - stjbmnpifs)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free